Bgb A317 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bgb A317. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bgb A317 Today - Breaking & Trending Today

RATIONALE-315 Data Support Perioperative Tislelizumab Plus Neoadjuvant Chemo in Resectable NSCLC

Published: February 20, 2024

Neoadjuvant tislelizumab plus platinum-based doublet chemotherapy followed by surgery and adjuvant tislelizumab demonstrated efficacy in resectable non–small cell lung cancer.

Source: onclive.com

Related Topics:

Federico CappuzzoHematology DepartmentPhase 3 Rationale 315 Trial Esmo Virtual PlenaryNeoadjuvant TislelizumabBgb A317Tislelizumab Plus Platinum Based Doublet Chemotherapy Resectable Non Small Cell Lung CancerPerioperative Tislelizumab Plus Neoadjuvant Chemo